"10.1371_journal.pone.0134904","plos one","2015-08-06T00:00:00Z","Benoit Visseaux; Charlotte Charpentier; Gilles Collin; Mélanie Bertine; Gilles Peytavin; Florence Damond; Sophie Matheron; Eric Lefebvre; Françoise Brun-Vézinet; Diane Descamps; ANRS CO5 HIV-2 Cohort","INSERM, IAME, UMR 1137, Paris, France; Univ Paris Diderot, IAME, UMR 1137, Sorbonne Paris Cité, Paris, France; AP-HP, Hôpital Bichat, Laboratoire de Virologie, Paris, France; AP-HP, Hôpital Bichat, Pharmacologie des antirétroviraux, Paris, France; AP-HP, Hôpital Bichat, Service des Maladies Infectieuses et Tropicales, Paris, France; Tobira Therapeutics, Inc., South San Francisco, CA, United States of America","Conceived and designed the experiments: BV CC GC. Performed the experiments: GC MB. Analyzed the data: BV GC CC FD DD SM GP FB. Contributed reagents/materials/analysis tools: EL GP. Wrote the paper: BV CC.","Eric Lefebvre is Chief Medical Officer for Tobira Pharmaceutics. This does not alter the authors' adherence to all PLOS ONE policies on sharing data and materials.","2015","08","Benoit Visseaux","BV",11,TRUE,3,2,8,2,TRUE,TRUE,FALSE,0,NA,FALSE
